Endocrine Pathology 2005-01-01

Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

Onder Onguru, Mary B Casey, Sabine Kajita, Nobuki Nakamura, Ricardo V Lloyd

Index: Endocr. Pathol. 16(4) , 253-77, (2005)

Full Text: HTML

Abstract

Prostaglandins (PG) are members of a large group of hormonally active fatty acids derived from free fatty acids. They are formed from arachidonic acid-the major PG precursor. Cyclooxygenase (COX)-1 and -2 are the rate-limiting steps in PG synthesis. COX-2 is overexpressed in many human non-endocrine and endocrine tumors including colon, breast, prostate, brain, thyroid, and pituitary. COX-2 has an important role in angiogenesis and tumor growth. Thromboxane synthase (TS) catalyzes the synthesis of thromboxane A2 (TXA2), which is derived from arachidonic acid and prostaglandin H2 and is a vasoconstrictor and inducer of platelet aggregation. TXA2 stimulates tumor growth and spread of some tumors and TS appears to have a critical role in tumorigenesis in some organ systems. In this review, we examine the role of COX-2 and TS in various non-endocrine tumors, especially colon, breast, prostate, and brain as well as in endocrine tumors. The accumulating evidence points to an increasingly important role of COX-2 and TS in tumor progression and metastasis.


Related Compounds

  • Prostaglandin H2

Related Articles:

What we know about primary dysmenorrhea today: a critical review.

2015-01-01

[Hum. Reprod. Update 21 , 762-78, (2015)]

Anti-peptide antibodies against the human blood platelet thromboxane A2/prostaglandin H2 receptor. Production, purification and characterization.

1993-05-25

[Biochem. Pharmacol. 45(10) , 2071-8, (1993)]

Evidence for coordinate, selective regulation of eicosanoid synthesis in platelet-derived growth factor-stimulated 3T3 fibroblasts and in HL-60 cells induced to differentiate into macrophages or neutrophils.

1988-12-25

[J. Biol. Chem. 263(36) , 19384-91, (1988)]

Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.

2002-01-01

[Thromb. Haemost. 87(1) , 114-21, (2002)]

Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.

2005-01-01

[Antioxid. Redox Signal. 7(1-2) , 185-201, (2005)]

More Articles...